Occidental Petroleum Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw strong operational and financial results, with production and free cash flow exceeding guidance. Leadership transition is underway, debt reduction remains a top priority, and the outlook is robust despite Middle East disruptions and market volatility.
-
The meeting highlighted record operational and financial achievements, a strengthened balance sheet, and a major leadership transition. Shareholders approved all proposals with strong support, and the dividend was increased over 8%. Strategic focus remains on efficiency, AI, and risk management.
Fiscal Year 2025
-
Record production and cost efficiencies drove strong free cash flow and debt reduction in 2025, with a leaner capital plan and 1% production growth targeted for 2026. The company remains focused on operational excellence, disciplined capital allocation, and sustainable shareholder returns.
-
Q3 saw record oil and gas production, strong cash flow, and significant cost reductions, with the OxyChem sale enabling accelerated debt reduction and capital returns. Guidance was raised for key segments, and 2026 spending will remain flexible amid market volatility.
-
Q2 2025 saw strong cash flow and operational outperformance despite lower oil prices, with $7.5B in debt repaid and $4B in divestitures since 2024. Stratos DAC hit milestones, and cost reductions drove improved margins, while OxyChem faces ongoing margin pressure from global oversupply.
-
Strong Q1 results with $3B operating cash flow, significant cost reductions, and debt repayment. Production guidance maintained, with efficiency gains offsetting rig reductions. Oman and low-carbon ventures show promising growth, while capital and OpEx guidance lowered for 2025.
-
The meeting highlighted record operational and financial results, major strategic initiatives like the CrownRock acquisition and STRATOS project, and strong progress on sustainability and deleveraging. All shareholder proposals passed with overwhelming support, and the board emphasized ongoing refreshment, diversity, and pay-for-performance alignment.
Fiscal Year 2024
-
Delivered $4.9B in free cash flow, record production, and met debt reduction targets in 2024. 2025 guidance includes $7.4–$7.6B in capital spend, stable production, and continued focus on high-return assets and debt reduction.
-
Q3 2024 saw record U.S. production, $1.5B free cash flow, and rapid debt reduction. CrownRock integration and low-carbon projects advanced, with full-year guidance raised across all segments. Capital plans remain flexible amid commodity volatility.
-
Q2 saw record production, strong free cash flow, and successful CrownRock integration, with $1.3B in free cash flow and $3B in debt reduction on track. Guidance was raised for production and midstream, while OxyChem was revised down due to global headwinds.